Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neuralgia 1Neoplasms 1Cancer Pain 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Tapentadol × Clear all
NCT07320781 2026-01-08

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Shaukat Khanum Memorial Cancer Hospital & Research Centre

Phase NA Completed
70 enrolled
Breast

Breast Neoplasms

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Completed
150 enrolled

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡